Cargando…

Recombinant and endogenous ways to produce methylated phospholipids in Escherichia coli

Escherichia coli is the daily workhorse in molecular biology research labs and an important platform microorganism in white biotechnology. Its cytoplasmic membrane is primarily composed of the phospholipids phosphatidylethanolamine (PE), phosphatidylglycerol (PG), and cardiolipin (CL). As in most ot...

Descripción completa

Detalles Bibliográficos
Autores principales: Kleetz, Julia, Vasilopoulos, Georgios, Czolkoss, Simon, Aktas, Meriyem, Narberhaus, Franz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590670/
https://www.ncbi.nlm.nih.gov/pubmed/34709431
http://dx.doi.org/10.1007/s00253-021-11654-8
_version_ 1784599031496835072
author Kleetz, Julia
Vasilopoulos, Georgios
Czolkoss, Simon
Aktas, Meriyem
Narberhaus, Franz
author_facet Kleetz, Julia
Vasilopoulos, Georgios
Czolkoss, Simon
Aktas, Meriyem
Narberhaus, Franz
author_sort Kleetz, Julia
collection PubMed
description Escherichia coli is the daily workhorse in molecular biology research labs and an important platform microorganism in white biotechnology. Its cytoplasmic membrane is primarily composed of the phospholipids phosphatidylethanolamine (PE), phosphatidylglycerol (PG), and cardiolipin (CL). As in most other bacteria, the typical eukaryotic phosphatidylcholine (PC) is not a regular component of the E. coli membrane. PC is known to act as a substrate in various metabolic or catabolic reactions, to affect protein folding and membrane insertion, and to activate proteins that originate from eukaryotic environments. Options to manipulate the E. coli membrane to include non-native lipids such as PC might make it an even more powerful and versatile tool for biotechnology and protein biochemistry. This article outlines different strategies how E. coli can be engineered to produce PC and other methylated PE derivatives. Several of these approaches rely on the ectopic expression of genes from natural PC-producing organisms. These include PC synthases, lysolipid acyltransferases, and several phospholipid N-methyltransferases with diverse substrate and product preferences. In addition, we show that E. coli has the capacity to produce PC by its own enzyme repertoire provided that appropriate precursors are supplied. Screening of the E. coli Keio knockout collection revealed the lysophospholipid transporter LplT to be responsible for the uptake of lyso-PC, which is then further acylated to PC by the acyltransferase-acyl carrier protein synthetase Aas. Overall, our study shows that the membrane composition of the most routinely used model bacterium can readily be tailored on demand. Key points • Escherichia coli can be engineered to produce non-native methylated PE derivatives. • These lipids can be produced by foreign and endogenous proteins. • Modification of E. coli membrane offers potential for biotechnology and research. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00253-021-11654-8.
format Online
Article
Text
id pubmed-8590670
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-85906702021-11-23 Recombinant and endogenous ways to produce methylated phospholipids in Escherichia coli Kleetz, Julia Vasilopoulos, Georgios Czolkoss, Simon Aktas, Meriyem Narberhaus, Franz Appl Microbiol Biotechnol Applied Microbial and Cell Physiology Escherichia coli is the daily workhorse in molecular biology research labs and an important platform microorganism in white biotechnology. Its cytoplasmic membrane is primarily composed of the phospholipids phosphatidylethanolamine (PE), phosphatidylglycerol (PG), and cardiolipin (CL). As in most other bacteria, the typical eukaryotic phosphatidylcholine (PC) is not a regular component of the E. coli membrane. PC is known to act as a substrate in various metabolic or catabolic reactions, to affect protein folding and membrane insertion, and to activate proteins that originate from eukaryotic environments. Options to manipulate the E. coli membrane to include non-native lipids such as PC might make it an even more powerful and versatile tool for biotechnology and protein biochemistry. This article outlines different strategies how E. coli can be engineered to produce PC and other methylated PE derivatives. Several of these approaches rely on the ectopic expression of genes from natural PC-producing organisms. These include PC synthases, lysolipid acyltransferases, and several phospholipid N-methyltransferases with diverse substrate and product preferences. In addition, we show that E. coli has the capacity to produce PC by its own enzyme repertoire provided that appropriate precursors are supplied. Screening of the E. coli Keio knockout collection revealed the lysophospholipid transporter LplT to be responsible for the uptake of lyso-PC, which is then further acylated to PC by the acyltransferase-acyl carrier protein synthetase Aas. Overall, our study shows that the membrane composition of the most routinely used model bacterium can readily be tailored on demand. Key points • Escherichia coli can be engineered to produce non-native methylated PE derivatives. • These lipids can be produced by foreign and endogenous proteins. • Modification of E. coli membrane offers potential for biotechnology and research. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00253-021-11654-8. Springer Berlin Heidelberg 2021-10-28 2021 /pmc/articles/PMC8590670/ /pubmed/34709431 http://dx.doi.org/10.1007/s00253-021-11654-8 Text en © The Author(s) 2021, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Applied Microbial and Cell Physiology
Kleetz, Julia
Vasilopoulos, Georgios
Czolkoss, Simon
Aktas, Meriyem
Narberhaus, Franz
Recombinant and endogenous ways to produce methylated phospholipids in Escherichia coli
title Recombinant and endogenous ways to produce methylated phospholipids in Escherichia coli
title_full Recombinant and endogenous ways to produce methylated phospholipids in Escherichia coli
title_fullStr Recombinant and endogenous ways to produce methylated phospholipids in Escherichia coli
title_full_unstemmed Recombinant and endogenous ways to produce methylated phospholipids in Escherichia coli
title_short Recombinant and endogenous ways to produce methylated phospholipids in Escherichia coli
title_sort recombinant and endogenous ways to produce methylated phospholipids in escherichia coli
topic Applied Microbial and Cell Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590670/
https://www.ncbi.nlm.nih.gov/pubmed/34709431
http://dx.doi.org/10.1007/s00253-021-11654-8
work_keys_str_mv AT kleetzjulia recombinantandendogenouswaystoproducemethylatedphospholipidsinescherichiacoli
AT vasilopoulosgeorgios recombinantandendogenouswaystoproducemethylatedphospholipidsinescherichiacoli
AT czolkosssimon recombinantandendogenouswaystoproducemethylatedphospholipidsinescherichiacoli
AT aktasmeriyem recombinantandendogenouswaystoproducemethylatedphospholipidsinescherichiacoli
AT narberhausfranz recombinantandendogenouswaystoproducemethylatedphospholipidsinescherichiacoli